X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs NOVARTIS - Comparison Results

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. NOVARTIS FDC LTD./
NOVARTIS
 
P/E (TTM) x 24.4 295.1 8.3% View Chart
P/BV x 4.9 25.1 19.3% View Chart
Dividend Yield % 1.0 1.5 67.1%  

Financials

 FDC LTD.   NOVARTIS
EQUITY SHARE DATA
    FDC LTD.
Mar-14
NOVARTIS
Mar-17
FDC LTD./
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs144855 16.8%   
Low Rs79666 11.9%   
Sales per share (Unadj.) Rs47.6219.0 21.7%  
Earnings per share (Unadj.) Rs7.619.1 39.8%  
Cash flow per share (Unadj.) Rs9.020.3 44.4%  
Dividends per share (Unadj.) Rs2.2510.00 22.5%  
Dividend yield (eoy) %2.01.3 153.8%  
Book value per share (Unadj.) Rs47.5307.0 15.5%  
Shares outstanding (eoy) m177.8329.96 593.6%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.33.5 67.4%   
Avg P/E ratio x14.639.8 36.7%  
P/CF ratio (eoy) x12.337.5 33.0%  
Price / Book Value ratio x2.32.5 94.5%  
Dividend payout %29.652.4 56.5%   
Avg Mkt Cap Rs m19,78422,779 86.9%   
No. of employees `000NA0.7 0.0%   
Total wages/salary Rs m1,2211,393 87.6%   
Avg. sales/employee Rs ThNM9,736.2-  
Avg. wages/employee Rs ThNM2,066.8-  
Avg. net profit/employee Rs ThNM849.0-  
INCOME DATA
Net Sales Rs m8,4596,562 128.9%  
Other income Rs m394702 56.1%   
Total revenues Rs m8,8527,264 121.9%   
Gross profit Rs m2,070259 799.6%  
Depreciation Rs m24936 693.9%   
Interest Rs m317 430.7%   
Profit before tax Rs m2,184917 238.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m606345 175.5%   
Profit after tax Rs m1,353572 236.5%  
Gross profit margin %24.53.9 620.3%  
Effective tax rate %27.737.6 73.7%   
Net profit margin %16.08.7 183.5%  
BALANCE SHEET DATA
Current assets Rs m4,3559,731 44.8%   
Current liabilities Rs m1,7921,830 97.9%   
Net working cap to sales %30.3120.4 25.2%  
Current ratio x2.45.3 45.7%  
Inventory Days Days4449 91.3%  
Debtors Days Days2525 98.0%  
Net fixed assets Rs m3,02557 5,288.5%   
Share capital Rs m179141 126.9%   
"Free" reserves Rs m8,2439,056 91.0%   
Net worth Rs m8,4539,196 91.9%   
Long term debt Rs m110-   
Total assets Rs m10,55711,499 91.8%  
Interest coverage x71.4128.4 55.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 140.4%   
Return on assets %13.15.0 260.2%  
Return on equity %16.06.2 257.3%  
Return on capital %23.510.1 233.9%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,146129 889.1%   
Fx outflow Rs m3551,734 20.5%   
Net fx Rs m791-1,605 -49.3%   
CASH FLOW
From Operations Rs m1,485-380 -391.3%  
From Investments Rs m-6204,208 -14.7%  
From Financial Activity Rs m-753-3,318 22.7%  
Net Cashflow Rs m113510 22.1%  

Share Holding

Indian Promoters % 68.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 4.7 2.0 235.0%  
FIIs % 7.5 1.6 468.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 21.5 88.4%  
Shareholders   23,730 41,647 57.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   WOCKHARDT LTD.  FULFORD INDIA  MERCK LTD  BIOCON LTD  J.B.CHEMICALS  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jun 21, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - GSK PHARMA COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS